Screening for M protein in the blood
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study screens healthy adults for a protein in the blood called M protein, which can be an early sign of certain blood conditions. It aims to catch these conditions early and monitor those with positive results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 30 years old or older.
- You must agree to join the study and sign a consent form.
- You must not have been previously diagnosed with a blood cancer or a B-cell disease.
- You must be willing to give a blood sample for testing.
- If your test shows signs of M protein, you must be willing to come back for more check-ups.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for adults at Zhujiang Hospital to test a new, highly sensitive method for detecting a protein called M protein in the blood. It helps doctors understand how common this protein is in different patients.
This trial screens first-degree relatives of people with multiple myeloma to check for early signs of the disease before symptoms. It may help doctors understand risk in families and find problems sooner if they occur.
This study looks at whether a simple blood test can help track multiple myeloma. It will measure a protein called soluble BCMA that may indicate how active the disease is, potentially helping doctors monitor patients without frequent bone marrow tests.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.
This study screens for MGUS, a precursor to certain blood cancers, in people who are Black or African American, or who have a close relative with a plasma cell disorder. If MGUS is found, you may be invited to continue in the study to monitor your health.
Hear when a new Monoclonal Gammopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.